Dermatitis from idoxuridine.
D000287:Administration, Topical; D000328:Adult; D003875:Drug Eruptions / Q000209:etiology*; D005260:Female; D006560:Herpes Labialis / Q000188:drug therapy*; D006801:Humans; D007065:Idoxuridine / Q000009:adverse effects* / Q000627:therapeutic use; D010328:Patch Tests; D012008:Recurrence
D007065:Idoxuridine